基于人工智能的身体成分分析发现黑色素瘤全身治疗期间肌肉萎缩和器官增大与生活质量相关
本研究为回顾性队列,纳入358例接受全身治疗并完成生活质量问卷的黑色素瘤患者,用TotalSegmentator测量116个胸腹部器官、脂肪、骨骼与肌肉的纵向体积。结果显示肝脏、脾脏和胆囊体积较大与躯体功能及角色功能下降、疲乏增加相关,而肌肉体积较大与躯体功能及角色功能升高、疲乏减少相关(p<0.05或p<0.01)。
要点
- AI测量的肌肉体积较大与躯体功能和角色功能升高、疲乏减少相关(p<0.01)。
- 肝脏、脾脏和胆囊体积较大与躯体功能和角色功能下降、疲乏增加相关(p<0.05)。
- 作者认为这些影像生物标志物有助于监测患者和评估治疗反应。
核心结论
- AI测量的身体与器官分析与接受全身治疗的黑色素瘤患者的生活质量存在显著关联;未来研究需理解其潜在原因并确定这些影像特征的预测能力。
研究设计与样本
- 回顾性队列,纳入358例接受全身治疗且完成生活质量问卷并有规律影像随访的黑色素瘤患者,用TotalSegmentator测量116个胸腹部器官、皮下与内脏脂肪、骨骼和肌肉的纵向体积,以EORTC-QLQ-C30评估躯体功能、角色功能和疲乏。
临床应用与阅片要点
- 作者认为这些影像生物标志物有助于监测患者和评估治疗反应,将患者功能与治疗期间的躯体变化联系起来,为制定同时考虑生活质量改善的疗效评价标准提供思路。
局限性
- 未来研究需理解其潜在原因并确定这些影像特征的预测能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Health-related quality of life (HRQoL) is emerging as an endpoint, adjunct to survival, in cancer treatment. For this reason, the European Organization for Research and Treatment of Cancer (EORTC) has developed standardized quality-of-life questionnaires to collect patient-reported outcome measurement (PROM), which so far have been widely used in clinical trials to evaluate the impact of new drugs on cancer patients. However, while these questionnaires comprehensively describe patient functions, little is known about their association with patient characteristics. This study aims to bridge this gap and investigate the association between patient body composition and HRQoL.
MATERIALS AND METHODS: A retrospective cohort of melanoma patients treated with systemic therapy who completed HRQoL questionnaires and had regular imaging follow-ups was included. The primary endpoint was the association between n = 116 AI-measured longitudinal volumes of thoracic and abdominal organs, subcutaneous and visceral fat, skeleton and muscles (estimated by TotalSegmentator), and physical functioning (PF), role functioning (RF) and fatigue (FA) (estimated by the EORTC-QLQ-C30).
RESULTS: The n = 358 patients were included. Our findings show larger liver, spleen, and gallbladder volumes associated with decreased PF and RF and an increase in FA (p < 0.05). Furthermore, larger muscle volumes were associated with an increase in PF and RF and a decrease in FA (p < 0.01).
DISCUSSION: Our findings show significant associations between AI-measured body and organ analysis and HRQoL in patients with melanoma on systemic treatment. Future research is needed to understand the underlying cause and determine the possible predictive ability of these imaging features.
KEY POINTS: Question Are changes in body composition associated with changes in HRQoL in melanoma patients undergoing systemic therapy? Findings AI-based body composition analysis shows that larger muscle volumes are linked to improved HRQoL, while organ enlargement is associated with a decline in it. Clinical relevance Our findings indicate new imaging biomarkers that can help monitor patients and evaluate treatment responses. These biomarkers link patient function to physical changes during treatment, offering insights for creating response evaluation criteria that also consider improvements in quality of life.
引用
- Fraterman I, Cerquin LE, de Ligt KM, et al. Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis. Eur Radiol. 2024. PMID: 39702633. doi:10.1007/s00330-024-11289-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。